Metastatic/locally advanced high-grade MTC

Clinical trials for Metastatic/locally advanced high-grade MTC explained in plain language.

Never miss a new study

Get alerted when new Metastatic/locally advanced high-grade MTC trials appear

Sign up with your email to follow new studies for Metastatic/locally advanced high-grade MTC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New drug tarlatamab takes on tough lung cancers

Disease control Recruiting now

This phase 2 trial is testing a drug called tarlatamab in 40 people with advanced small-cell lung cancer or other poorly differentiated neuroendocrine cancers. The drug is given by IV and aims to shrink tumors. Researchers will also study blood and tumor samples to understand why…

Matched conditions: METASTATIC/LOCALLY ADVANCED HIGH-GRADE MTC

Phase 2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control

Last updated Sep 11, 2026 00:00 UTC

Metastatic/locally advanced high-grade MTC

Get alerted when new Metastatic/locally advanced high-grade MTC trials appear

New drug tarlatamab takes on tough lung cancers